{"organizations": [], "uuid": "b9f8ec4cbff3a5adbbf98b4f468922d74917c407", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180129.html", "section_title": "Archive News &amp; Video for Monday, 29 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-mmj-phytotech-says-co-to-buy-strat/brief-mmj-phytotech-says-co-to-buy-strategic-position-in-dosecann-inc-idUSFWN1PO17F", "country": "US", "domain_rank": 408, "title": "BRIEF-MMJ Phytotech Says Co To Buy Strategic Position In Dosecann Inc", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.466, "site_type": "news", "published": "2018-01-30T07:42:00.000+02:00", "replies_count": 0, "uuid": "b9f8ec4cbff3a5adbbf98b4f468922d74917c407"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-mmj-phytotech-says-co-to-buy-strat/brief-mmj-phytotech-says-co-to-buy-strategic-position-in-dosecann-inc-idUSFWN1PO17F", "ord_in_thread": 0, "title": "BRIEF-MMJ Phytotech Says Co To Buy Strategic Position In Dosecann Inc", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "dosecann inc", "sentiment": "negative"}, {"name": "mmj phytotech ltd", "sentiment": "negative"}, {"name": "phytotech says co", "sentiment": "negative"}, {"name": "nd healthcare company dosecann inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 30 (Reuters) - Mmj Phytotech Ltd:\n* TO ACQUIRE STRATEGIC POSITION IN CANADIAN SPECIALTY PHARMA AND HEALTHCARE COMPANY DOSECANN INC\n* MMJ TO INVEST C$2.5 MILLION IN DOSECANN BY WAY OF CONVERTIBLE DEBENTURES AT AN PRE-MONEY VALUATION OF C$11.5 MILLION Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-30T07:42:00.000+02:00", "crawled": "2018-01-30T18:50:34.011+02:00", "highlightTitle": ""}